Cronos (CRON) Total Non-Current Liabilities (2016 - 2026)
Cronos (CRON) posted quarterly Total Non-Current Liabilities of $47.5 million for Q1 2026, up 23.65% year-over-year from $38.5 million in Q1 2025, and down 11.04% quarter-over-quarter from $53.4 million in Q4 2025.
Cronos (CRON) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends
Cronos' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $47.5 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 23.65% year-over-year to $47.5 million; the TTM figure through Mar 2026 stood at $47.5 million (up 23.65% YoY), while the FY2025 annual figure was $53.4 million, changed N/A from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $47.5 million, down from $53.4 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $73.8 million in Q4 2022, with the low at $30.7 million in Q2 2023.
- The 5-year median for Total Non-Current Liabilities is $45.6 million (2022), against an average of $45.2 million.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities sank 85.45% in 2022, then soared 59.5% in 2024.
- Cronos' Total Non-Current Liabilities stood at $73.8 million in 2022, then dropped by 12.15% to $64.8 million in 2023, then fell by 20.42% to $51.6 million in 2024, then rose by 3.62% to $53.4 million in 2025, then dropped by 11.04% to $47.5 million in 2026.
- Business Quant data shows CRON's Total Non-Current Liabilities at $47.5 million in Q1 2026, $53.4 million in Q4 2025, and $45.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 32.31 Bn | 30.63 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.87 Bn | 17.98 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 334.00 Mn |
| 10 | Cronos | 1.22 Bn | 420.95 Mn | 28.45 Mn | 62.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.42 Mn |
| Mar 31, 2026 | 47.55 Mn |
| Dec 31, 2025 | 53.45 Mn |
| Sep 30, 2025 | 45.66 Mn |
| Jun 30, 2025 | 44.34 Mn |
| Mar 31, 2025 | 38.45 Mn |
| Sep 30, 2024 | 51.58 Mn |
| Jun 30, 2024 | 34.12 Mn |
| Mar 31, 2024 | 34.72 Mn |
| Dec 31, 2023 | 64.81 Mn |
| Sep 30, 2023 | 32.34 Mn |
| Jun 30, 2023 | 30.65 Mn |
| Mar 31, 2023 | 33.18 Mn |
| Dec 31, 2022 | 73.78 Mn |
| Sep 30, 2022 | 46.23 Mn |
| Jun 30, 2022 | 46.68 Mn |
| Mar 31, 2022 | 45.53 Mn |
| Dec 31, 2021 | 81.59 Mn |
| Sep 30, 2021 | 44.25 Mn |
| Jun 30, 2021 | 208.70 Mn |